Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma

Neuroscience

Volumn 150, Issue 1, 2007, Pages 168-181

  Genovese, T ^a,b   Mazzon, E ^a,b   Crisafulli, C ^a   Esposito, E ^b,c   Di Paola, R ^a,b   Muia C ^a   Di Bella, P ^b   Meli, R ^c   Bramanti, P ^b   Cuzzocrea, S ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

dexamethasone; etanercept; iNOS; myeloperoxidase activity; nitrotyrosine; spinal cord injury

Indexed keywords

3 NITROTYROSINE; CYTOKINE; DEXAMETHASONE; DNA NUCLEOTIDYLEXOTRANSFERASE; ETANERCEPT; FAS LIGAND; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA; URIDINE TRIPHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CLIP; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DURA MATER; EDEMA; EXPERIMENTAL STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LAMINECTOMY; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SPINAL CORD INJURY; SPINAL CORD LESION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BCL-2-ASSOCIATED X PROTEIN; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; IMMUNOGLOBULIN G; IN SITU NICK-END LABELING; INTERLEUKIN-1BETA; LAMINECTOMY; MALE; MICE; NEUTROPHILS; NITRIC OXIDE SYNTHASE TYPE II; PEROXIDASE; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR; SPINAL CORD INJURIES; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE;

EID: 36749055911     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.06.059     Document Type: Article

References (49)

1. Amar A.P., and Levy M.L. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 44 (1999) 1027-1039 discussion 1039-1040
2. Baptiste D.C., and Fehlings M.G. Pharmacological approaches to repair the injured spinal cord. J Neurotrauma 23 (2006) 318-334
3. Barbany G., and Persson H. Regulation of neurotrophin mRNA expression in the rat brain by glucocorticoids. Eur J Neurosci 4 (1992) 396-403
4. Basso D.M., Beattie M.S., and Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12 (1995) 1-21
5. Bazzoni F., and Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 334 (1996) 1717-1725
6. Bendele A.M., McComb J., Gould T., Frazier J., Chlipala E., Seely J., Kieft G., and Edwards III C.K. Effects of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) alone and in combination with methotrexate in adjuvant arthritic rats. Clin Exp Rheumatol 17 (1999) 553-560
7. Bendele A.M., McComb J., Gould T., Frazier J., Chlipala E.S., Seely J., Kieft G., Wolf J., and Edwards III C.K. Combination benefit of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) and dexamethasone or indomethacin in adjuvant arthritic rats. Inflamm Res 48 (1999) 453-460
8. Bond W.S. Toxic reactions and side effects of glucocorticoids in man. Am J Hosp Pharm 34 (1977) 479-485
9. Caldenhoven E., Liden J., Wissink S., Van de Stolpe A., Raaijmakers J., Koenderman L., Okret S., Gustafsson J.A., and Van der Saag P.T. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 9 (1995) 401-412
10. Carlson S.L., Parrish M.E., Springer J.E., Doty K., and Dossett L. Acute inflammatory response in spinal cord following impact injury. Exp Neurol 151 (1998) 77-88
11. de Castro Jr. R., Hughes M.G., Xu G.Y., Clifton C., Calingasan N.Y., Gelman B.B., and McAdoo D.J. Evidence that infiltrating neutrophils do not release reactive oxygen species in the site of spinal cord injury. Exp Neurol 190 (2004) 414-424
12. Genovese T., Mazzon E., Crisafulli C., Di Paola R., Muia C., Bramanti P., and Cuzzocrea S. Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J Pharmacol Exp Ther 316 (2006) 1006-1016
13. Genovese T., Mazzon E., Di Paola R., Crisafulli C., Muia C., Bramanti P., and Cuzzocrea S. Increased oxidative-related mechanisms in the spinal cord injury in old rats. Neurosci Lett 393 (2006) 141-146
14. Genovese T., Mazzon E., Di Paola R., Cannavo G., Muia C., Bramanti P., and Cuzzocrea S. Role of endogenous ligands for the peroxisome proliferators activated receptors alpha in the secondary damage in experimental spinal cord trauma. Exp Neurol 194 (2005) 267-278
15. Genovese T., Mazzon E., Muia C., Patel N.S., Threadgill M.D., Bramanti P., De Sarro A., Thiemermann C., and Cuzzocrea S. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma. J Pharmacol Exp Ther 312 (2005) 449-457
16. Genovese T., Mazzon E., Mariotto S., Menegazzi M., Cardali S., Conti A., Suzuki H., Bramanti P., and Cuzzocrea S. Modulation of nitric oxide homeostasis in a mouse model of spinal cord injury. J Neurosurg Spine 4 (2006) 145-153
17. Genovese T., Mazzon E., Menegazzi M., Di Paola R., Muia C., Crisafulli C., Bramanti P., Suzuki H., and Cuzzocrea S. Neuroprotection and enhanced recovery with Hypericum perforatum extract after experimental spinal cord injury in mice. Shock 25 (2006) 608-617
18. Gonzalez Deniselle M.C., Gonzalez S., Piroli G., Ferrini M., Lima A.E., and De Nicola A.F. Glucocorticoid receptors and actions in the spinal cord of the wobbler mouse, a model for neurodegenerative diseases. J Steroid Biochem Mol Biol 60 (1997) 205-213
19. Gonzalez R., Glaser J., Liu M.T., Lane T.E., and Keirstead H.S. Reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury. Exp Neurol 184 (2003) 456-463
20. Gonzalez S., Labombarda F., Gonzalez Deniselle M.C., Saravia F.E., Roig P., and De Nicola A.F. Glucocorticoid effects on Fos immunoreactivity and NADPH-diaphorase histochemical staining following spinal cord injury. Brain Res 912 (2001) 144-153
21. Gorio A., Madaschi L., Di Stefano B., Carelli S., Di Giulio A.M., De Biasi S., Coleman T., Cerami A., and Brines M. Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury. Proc Natl Acad Sci U S A 102 (2005) 16379-16384
22. Han C.W., Choi J.H., Kim J.M., Kim W.Y., Lee K.Y., and Oh G.T. Glucocorticoid-mediated repression of inflammatory cytokine production in fibroblast-like rheumatoid synoviocytes is independent of nuclear factor-kappaB activation induced by tumour necrosis factor alpha. Rheumatology (Oxford) 40 (2001) 267-273
23. Harrington J.F., Messier A.A., Levine A., Szmydynger-Chodobska J., and Chodobski A. Shedding of tumor necrosis factor type 1 receptor after experimental spinal cord injury. J Neurotrauma 22 (2005) 919-928
24. Hayashi M., Ueyama T., Nemoto K., Tamaki T., and Senba E. Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury. J Neurotrauma 17 (2000) 203-218
25. Hurlbert R.J. Strategies of medical intervention in the management of acute spinal cord injury. Spine 31 (2006) S16-S21 discussion S36.
26. Joshi M., and Fehlings M.G. Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcomes, and histopathology. J Neurotrauma 19 (2002) 175-190
27. Joshi M., and Fehlings M.G. Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 2. Quantitative neuroanatomical assessment and analysis of the relationships between axonal tracts, residual tissue, and locomotor recovery. J Neurotrauma 19 (2002) 191-203
28. Kapadia S., Torre-Amione G., Yokoyama T., and Mann D.L. Soluble TNF binding proteins modulate the negative inotropic properties of TNF-alpha in vitro. Am J Physiol 268 (1995) H517-H525
29. Lim G., Wang S., and Mao J. Central glucocorticoid receptors modulate the expression of spinal cannabinoid receptors induced by chronic morphine exposure. Brain Res 1059 (2005) 20-27
30. Lim G., Wang S., Zeng Q., Sung B., and Mao J. Spinal glucocorticoid receptors contribute to the development of morphine tolerance in rats. Anesthesiology 102 (2005) 832-837
31. Machuca C., Mendoza-Milla C., Cordova E., Mejia S., Covarrubias L., Ventura J., and Zentella A. Dexamethasone protection from TNF-alpha-induced cell death in MCF-7 cells requires NF-kappaB and is independent from AKT. BMC Cell Biol 7 (2006) 9
32. Marlier L.N., Csikos T., Rebaudengo N., Borboni P., Patacchioli F.R., Angelucci L., Privat A., and Lauro R. Distribution of glucocorticoid receptor mRNA in the rat spinal cord. Neuroreport 6 (1995) 2245-2249
33. Maeda K., Yoshida K., Ichimiya I., and Suzuki M. Dexamethasone inhibits tumor necrosis factor-alpha-induced cytokine secretion from spiral ligament fibrocytes. Hear Res 202 (2005) 154-160
34. McComb J., Gould T., Chlipala E., Sennelo G., Frazier J., Kieft G., Seely J., Edwards III C.K., and Bendele A. Antiarthritic activity of soluble tumor necrosis factor receptor type I forms in adjuvant arthritis: correlation of plasma levels with efficacy. J Rheumatol 26 (1999) 1347-1351
35. McTigue D.M., Popovich P.G., Jakeman L.B., and Stokes B.T. Strategies for spinal cord injury repair. Prog Brain Res 128 (2000) 3-8
36. Merrill J.E., Ignarro L.J., Sherman M.P., Melinek J., and Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 151 (1993) 2132-2141
37. Mocchetti I., and Wrathall J.R. Neurotrophic factors in central nervous system trauma. J Neurotrauma 12 (1995) 853-870
38. Mullane K. Neutrophil-platelet interactions and post-ischemic myocardial injury. Prog Clin Biol Res 301 (1989) 39-51
39. Orti E., Magarinos A.M., and De Nicola A.F. Evidence of high affinity, stereoselective binding sites for [3H]-aldosterone in the spinal cord. Neuroendocrinology 43 (1986) 404-409
40. Orti E., Moses D.F., Grillo C., and De Nicola A.F. Glucocorticoid regulation of glycerol phosphate dehydrogenase and ornithine decarboxylase activities in the spinal cord of the rat. J Neurochem 48 (1987) 425-431
41. Pineau I., and Lacroix S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J Comp Neurol 500 (2007) 267-285
42. Reul J.M., and de Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117 (1985) 2505-2511
43. Sayer F.T., Kronvall E., and Nilsson O.G. Methylprednisolone treatment in acute spinal cord injury: the myth challenged through a structured analysis of published literature. Spine J 6 (2006) 335-343
44. Streit W.J., Semple-Rowland S.L., Hurley S.D., Miller R.C., Popovich P.G., and Stokes B.T. Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp Neurol 152 (1998) 74-87
45. Teng Y.D., Mocchetti I., Taveira-DaSilva A.M., Gillis R.A., and Wrathall J.R. Basic fibroblast growth factor increases long-term survival of spinal motor neurons and improves respiratory function after experimental spinal cord injury. J Neurosci 19 (1999) 7037-7047
46. Tsutsumi S., Ueta T., Shiba K., Yamamoto S., and Takagishi K. Effects of the Second National Acute Spinal Cord Injury Study of high-dose methylprednisolone therapy on acute cervical spinal cord injury-results in spinal injuries center. Spine 31 (2006) 2992-2996 discussion 2997.
47. Vaquero J., Zurita M., Oya S., Aguayo C., and Bonilla C. Early administration of methylprednisolone decreases apoptotic cell death after spinal cord injury. Histol Histopathol 21 (2006) 1091-1102
48. Wang S., Lim G., Zeng Q., Sung B., Yang L., and Mao J. Central glucocorticoid receptors modulate the expression and function of spinal NMDA receptors after peripheral nerve injury. J Neurosci 25 (2005) 488-495
49. Weaver L.C., Gris D., Saville L.R., Oatway M.A., Chen Y., Marsh D.R., Hamilton E.F., and Dekaban G.A. Methylprednisolone causes minimal improvement after spinal cord injury in rats, contrasting with benefits of an anti-integrin treatment. J Neurotrauma 22 (2005) 1375-1387